- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05835063
A Study to Improve Physician-Youth Communication and Medical Decision Making (CHATT)
June 3, 2025 updated by: Melissa Cousino, University of Michigan
We Chatt (Communication, Hopes, Action, Tips and Team) A Study to Improve Physician-Youth Communication and Medical Decision Making
The goal of this study is improving patient-centered communication for young people with advanced heart disease.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Physician Inclusion Criteria:
- Physician participants will be recruited from the Division of Pediatric Cardiology at the University of Michigan. All physicians with dedicated clinical effort will be eligible.
- Eligible physicians must anticipate remaining on staff >1 year
Patient/Caregiver Inclusion Criteria:
- Patients 12-24 years old with heart failure symptoms meeting criteria for New York Heart Association (NYHA) Class II - IV heart failure
- One parent/caregiver of patient participants meeting inclusion criteria will also be eligible
Physician Exclusion Criteria:
- Not a physician at University of Michigan in the Division of Pediatric Cardiology
Patient/Caregiver Exclusion Criteria:
- Patients with significant cognitive/developmental delay with potential to impact study participation will be excluded from the study due to the focus on physician-youth communication.
- Parents and parent/caregivers that are non-English speaking will be excluded from this pilot study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Usual care
|
Usual/standard care will be provided.
Physicians randomized to the control arm will not receive training in the WE CHATT communication intervention.
|
|
Experimental: We Chatt communication tool
|
This arm involves the collaborative completion of a 2-page communication preferences document between a primary physician and an adolescent/young adult patient.
Physicians will participate in a 1-hour training led by study principal investigator featuring didactic, multimedia, and experiential-based learning to support the facilitation of the WE CHATT intervention with patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physician Overall Satisfaction With the We Chatt Intervention Based on the Post Clinician Survey
Time Frame: 2 weeks (after intervention)
|
Satisfaction was based on the answers for 12 questions in which clinicians selected from a Likert scale from strongly disagree (1) -Strongly agree (5).
The scores ranged from 12-60; higher scores indicated greater satisfaction.
|
2 weeks (after intervention)
|
|
Patient/Caregiver Overall Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver Survey
Time Frame: 2 weeks (after intervention)
|
Parent/Caregiver completed 12 questions in which participants selected from a Likert scale from Strongly disagree (1) to Strongly agree (5).
The scores ranged from 12-60; higher scores indicated greater satisfaction.
|
2 weeks (after intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physician Satisfaction With the We Chatt Intervention From Physicians Based on the Post Clinician Survey
Time Frame: 2 weeks (after intervention)
|
Physicians answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
|
2 weeks (after intervention)
|
|
Patient/Caregiver Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver Survey
Time Frame: 2 weeks (after intervention)
|
Patient/Caregiver answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
|
2 weeks (after intervention)
|
|
Time (Measured in Minutes) to Complete We Chatt the Intervention by Clinicians
Time Frame: 30 minutes (approximately)
|
Number of minutes to complete the intervention was collected on clinician survey.
|
30 minutes (approximately)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Melissa Cousino, PhD, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2023
Primary Completion (Actual)
June 7, 2024
Study Completion (Actual)
June 7, 2024
Study Registration Dates
First Submitted
April 17, 2023
First Submitted That Met QC Criteria
April 17, 2023
First Posted (Actual)
April 28, 2023
Study Record Updates
Last Update Posted (Actual)
June 18, 2025
Last Update Submitted That Met QC Criteria
June 3, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00231699
- 5K23HL145096-04 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure NYHA Class II
-
CVRx, Inc.Enrolling by invitationHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class IIIUnited States
-
Vanderbilt University Medical CenterWithdrawnHeart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IUnited States
-
Foundry Innovation & Research 1, Limited (FIRE1)NAMSA; Baim Institute for Clinical ResearchNot yet recruitingHeart Failure | NYHA Class III Heart Failure | NYHA Class II Heart Failure
-
University Hospital, Gentofte, CopenhagenUnknownChronic Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVDenmark
-
Comunicare Solutions SAKU Leuven; Jessa Hospital; Cliniques universitaires Saint-Luc- Université Catholique... and other collaboratorsRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVBelgium
-
Indiana UniversityCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IUnited States
-
Elpen Pharmaceutical Co. Inc.WithdrawnHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV
-
Ahmad Abdullah SalawiCompletedHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IVSaudi Arabia
-
Alexandria UniversityCompletedHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IVEgypt
-
John ParissisCompletedHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure NYHA Class IGreece
Clinical Trials on We Chatt communication tool
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancerUnited States
-
National University of SingaporeNational Medical Research Council (NMRC), SingaporeCompleted
-
Shanghai Zhongshan HospitalNot yet recruitingICU Patients | Communication Barriers | Eye-tracking Technology
-
University of Illinois at ChicagoAmerican Cancer Society, Inc.; University of Maryland, Baltimore County; Project...Not yet recruiting
-
University Hospital, ToulouseCompletedCommunication, NonverbalFrance
-
University of California, San FranciscoNational Institute on Aging (NIA); Mount Zion Health FundCompleted
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
NYU Langone HealthRecruiting
-
Icahn School of Medicine at Mount SinaiMoi UniversityCompletedHypertension | High Blood PressureKenya
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH); Massachusetts General Hospital; Beth...CompletedHIV-infection/AIDSUnited States